Indazole derivative, preparation method therefor, and pharmaceutical application thereof
US12325696B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jun 18, 2020 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | Jun 13, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An indazole derivative, a preparation method therefor, and a pharmaceutical application thereof. In particular, the present invention relates to an indazole derivative represented by general formula (I), a preparation method therefor, a pharmaceutical composition comprising the derivative, and a use of the derivative as an estrogen receptor modulator in the prevention and/or treatment of an estrogen receptor mediated or dependent disease or condition, the disease being particularly preferably breast cancer. The definition of each substituent in the general formula (I) is the same as that in the description.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.